3D Printing has become a “Hot Topic” in Pharmaceutics: The versatility of this novel production technique offers a large range of advantages and will likely enable substantially improved medications in the future. Personalized medicine with individualized dosing adapted to the specific needs of each patient is just one of the many possible breakthroughs that might become reality. It is telling that in our societies we are used to have a broad choice of standard sizes and shapes for our clothes, but generally only a very limited choice of dose strengths of medicines.
However, there are numerous hurdles that are still to be overcome for 3D printing in pharmaceutics, and the real potential of this revolutionizing technique has not yet fully been exploited. This “Hot Topic Day” will give on overview on the current state of the art in this rapidly evolving field and point out possible bottlenecks and strategies how to address them. Technical aspects will be treated, but also clinical applications and quality control tools. The entire spectrum: from the basic concepts, technical manufacturing features, the portfolio of suitable excipients (especially polymers), quality assurance and treatment of patients will be covered.
World-wide leading experts in the field from academia and industry will present and discuss with the audience. This includes pioneers in this domain like Prof. Abdul Basit from the University College London and Prof. Andrea Gazzaniga from the University of Milano, who will talk about “4D printing” (3D printing of systems which undergo pre-programmed shape modifications over time). The engineer Dr. Mirzaali from the University of Delft will explain what is feasible today and what might be possible tomorrow. Dr. Goole from the University of Brussels will give an overview on the use of 3D printing with biodegradable polymers, and Dr. Goyanes from the company FabRx will report on translation into industrial applications. Prof. Rantanen from the University of Copenhagen will explain which analytical aspects are of key importance and how an efficient quality assurance system can be envisaged. Clinical examples of applications of 3D printed medicines will be given by Dr. Trenfield from the University College London.
In addition to these oral lectures, poster presentations will give the opportunity to learn about the latest research findings in the field of 3D printing in pharmaceutics. Furthermore, an industrial exhibition will allow getting into contact with companies working in this “hot field” and to learn about ongoing international research consortia, e.g. of the Interreg Project “Site-Specific Drug Delivery” (https://www.interreg2seas.eu/fr/Site-Drug).